Get the Stockscreener App
22.55
0.89%
0.198
Lifemd Inc stock is traded at $22.55, with a volume of 1,305.
It is up +0.89% in the last 24 hours and up +0.22% over the past month.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
See More
Previous Close:
$22.35
Open:
$22.37
24h Volume:
1,305
Relative Volume:
0.51
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.55%
1M Performance:
+0.22%
6M Performance:
-4.64%
1Y Performance:
+0.67%
1-Day Range:
$22.35
$22.60
1-Week Range:
$22.35
$22.79
52-Week Range:
$18.50
$27.44
Lifemd Inc Stock (LFMDP) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
866 351 5907
Address
236 Fifth Avenue, Suite 400, New York
Compare LFMDP vs HITI, PETS, RDGT, POM, WGRX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
22.60 | 0 | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.49 | 219.60M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
2.715 | 58.42M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
1.7213 | 31.48M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
POM
Pomdoctor Ltd Adr
|
0.24 | 29.20M | 0 | 0 | 0 | 0.00 |
|
WGRX
Wellgistics Health Inc
|
0.2132 | 22.42M | 28.99M | -39.20M | -3.34M | 0.00 |
Lifemd Inc Stock (LFMDP) Latest News
LFMDP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LFMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LifeMD, Inc. (LFMD) Investor Outlook: Exploring A 232.73% Potential Upside - DirectorsTalk Interviews
LifeMD: Still My Favorite Bargain On The Market (NASDAQ:LFMD) - Seeking Alpha
LifeMD, Inc. Hits New 52-Week Low at $2.61 Amidst Declining Stock Performance - Markets Mojo
Update Recap: Can LifeMD Inc stock outperform in a bear marketJuly 2025 Closing Moves & Growth Focused Stock Reports - baoquankhu1.vn
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 - The Manila Times
LifeMD, Inc. to Report Financial Results for 2025 on March 9, 2026 - Quiver Quantitative
LifeMD sets March 9 date to reveal Q4 and 2025 results - Stock Titan
LifeMD, Inc. (LFMD) Stock Analysis: Exploring a Potential 218.97% Upside in the Thriving Telehealth Sector - DirectorsTalk Interviews
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Understanding the Setup: (LFMDP) and Scalable Risk - Stock Traders Daily
Highs Report: Should I add LifeMD Inc stock to my portfolio2025 Geopolitical Influence & Advanced Technical Signal Analysis - baoquankhu1.vn
Volume Summary: Is LifeMD Inc stock good for income investorsMarket Performance Report & Low Drawdown Momentum Ideas - baoquankhu1.vn
Ideas Watch: Should I add LifeMD Inc stock to my portfolioWeekly Stock Report & Entry Point Confirmation Signals - baoquankhu1.vn
Aug Summary: Is LifeMD Inc. stock a safe haven assetJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - mfd.ru
Can LifeMD Inc. stock hit analyst price targetsTrend Reversal & Risk Adjusted Buy and Sell Alerts - mfd.ru
Is LifeMD Inc. stock a safe haven assetMarket Rally & Long-Term Growth Plans - mfd.ru
LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 230% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Is LifeMD Inc. stock vulnerable to regulatory risksMarket Rally & AI Powered Market Entry Strategies - mfd.ru
Why Investors Shouldn't Be Surprised By LifeMD, Inc.'s (NASDAQ:LFMD) 31% Share Price Plunge - simplywall.st
Little Excitement Around LifeMD, Inc.'s (NASDAQ:LFMD) Revenues As Shares Take 31% Pounding - 富途牛牛
What’s the beta of LifeMD Inc. stockWall Street Watch & AI Enhanced Trade Execution Alerts - mfd.ru
Can LifeMD Inc. continue delivering strong returnsWeekly Risk Report & Daily Chart Pattern Signal Reports - mfd.ru
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
LifeMD options imply 13.7% move in share price post-earnings - MSN
LifeMD: Pure Telehealth Play With In-House Pharmacy Integration (NASDAQ:LFMD) - Seeking Alpha
LifeMD, Inc. (LFMD) Stock Analysis: Unveiling a 174% Potential Upside in the Telehealth Sector - DirectorsTalk Interviews
Precision Trading with Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Risk Zones - Stock Traders Daily
Portfolio Update: Is LifeMD Inc a strong growth stockForecast Cut & Long-Term Growth Portfolio Plans - baoquankhu1.vn
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
How The New LifeMD (LFMD) Price Target Is Shaping The Investment Story - Yahoo Finance
LifeMD (NASDAQ:LFMD) Shares Up 2.3%Still a Buy? - MarketBeat
Can LifeMD Inc. be the next market leaderPrice Volatility Patterns & Small Budget Trading Plans - bollywoodhelpline.com
After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers - Nasdaq
LifeMD Divests WorkSimpli Stake to Focus on Healthcare - MSN
Can LifeMD Inc. stock beat market expectations this quarterBuy Signal & Smart Money Movement Tracker - ulpravda.ru
Retail Surge: Is LifeMD Inc. stock a top momentum playMarket Sentiment Report & Free Expert Verified Stock Movement Alerts - ulpravda.ru
What The Recent Setbacks And Progress Mean For LifeMD's Story And Valuation - Yahoo Finance
Why LifeMD Inc. stock is considered a top pickGold Moves & Safe Swing Trade Setups - ulpravda.ru
Will LifeMD Inc. stock reach all time highs in 2025Quarterly Portfolio Review & Risk Managed Investment Entry Signals - ulpravda.ru
Aug Final Week: Will LifeMD Inc. stock reach all time highs in 2025 - ulpravda.ru
Why LifeMD (LFMD) Is Up 15.2% After Securing Credit Line And Adding Oral Wegovy Access - Yahoo Finance
LifeMD secures new revolving credit facility for growth - MSN
Why LifeMD Inc. stock could rally in 2025Trading Volume Trends & Superior Wealth Building - ulpravda.ru
symbol__ Stock Quote Price and Forecast - CNN
(LFMD) and the Role of Price-Sensitive Allocations - Stock Traders Daily
LifeMD Secures New Revolving Credit Facility for Growth - The Globe and Mail
LifeMD stock maintains Buy rating at H.C. Wainwright on Wegovy pill launch By Investing.com - Investing.com South Africa
LifeMD (LFMD) Secures $50 Million Credit Facility with Citizens Bank - GuruFocus
Lifemd Inc Stock (LFMDP) Financials Data
There is no financial data for Lifemd Inc (LFMDP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
7.56%
1.02%
Cap:
|
Volume (24h):